Dr. Samir Rashmikant Patel , M.D.,  who was recently
appointed to Board of Directors of Directors of $CYDY shows his conviction for the firm and its #drug candidate, #leronlimab. #InsidersTrading #clinicaltrials  $GILD $LLY $JNJ @WSJ @NEWYORKTI @NewsweeK
https://t.co/DrmzMLfhpq